Millennium Management
ADAP

Millennium Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-94,283
Closed -$18.6K 3942
2025
Q1
$18.6K Buy
94,283
+64,724
+219% +$12.8K ﹤0.01% 3883
2024
Q4
$15.9K Sell
29,559
-685,791
-96% -$369K ﹤0.01% 3994
2024
Q3
$680K Sell
715,350
-64,265
-8% -$61.1K ﹤0.01% 3134
2024
Q2
$760K Sell
779,615
-45,564
-6% -$44.4K ﹤0.01% 3013
2024
Q1
$1.3M Buy
825,179
+384,147
+87% +$607K ﹤0.01% 2816
2023
Q4
$350K Buy
441,032
+140,971
+47% +$112K ﹤0.01% 3343
2023
Q3
$234K Sell
300,061
-351,901
-54% -$274K ﹤0.01% 3547
2023
Q2
$603K Buy
651,962
+352,370
+118% +$326K ﹤0.01% 3180
2023
Q1
$327K Buy
299,592
+134,933
+82% +$147K ﹤0.01% 3617
2022
Q4
$240K Buy
164,659
+153,255
+1,344% +$223K ﹤0.01% 4008
2022
Q3
$12K Sell
11,404
-110,718
-91% -$117K ﹤0.01% 5016
2022
Q2
$208K Sell
122,122
-1,325,492
-92% -$2.26M ﹤0.01% 4437
2022
Q1
$2.98M Sell
1,447,614
-195,864
-12% -$403K ﹤0.01% 2752
2021
Q4
$6.16M Buy
1,643,478
+58,629
+4% +$220K ﹤0.01% 2048
2021
Q3
$8.19M Buy
1,584,849
+654,434
+70% +$3.38M ﹤0.01% 1714
2021
Q2
$3.96M Sell
930,415
-686,118
-42% -$2.92M ﹤0.01% 2395
2021
Q1
$8.58M Sell
1,616,533
-111,023
-6% -$590K 0.01% 1537
2020
Q4
$9.31M Buy
1,727,556
+1,022,800
+145% +$5.51M 0.01% 1395
2020
Q3
$5.62K Sell
704,756
-1,082,848
-61% -$8.64K 0.01% 1337
2020
Q2
$17.9M Buy
1,787,604
+331,725
+23% +$3.32M 0.02% 605
2020
Q1
$3.96M Buy
1,455,879
+962,644
+195% +$2.62M 0.01% 1212
2019
Q4
$592K Sell
493,235
-421,181
-46% -$506K ﹤0.01% 2666
2019
Q3
$1.38M Sell
914,416
-404,876
-31% -$611K ﹤0.01% 2173
2019
Q2
$5.3M Sell
1,319,292
-1,269,448
-49% -$5.1M 0.01% 1454
2019
Q1
$11.1M Buy
2,588,740
+490,468
+23% +$2.11M 0.02% 1011
2018
Q4
$12.1M Sell
2,098,272
-74,376
-3% -$428K 0.02% 914
2018
Q3
$29.5M Buy
2,172,648
+1,323,793
+156% +$18M 0.04% 598
2018
Q2
$10.1M Sell
848,855
-628,786
-43% -$7.46M 0.01% 1194
2018
Q1
$16.6M Buy
1,477,641
+672,046
+83% +$7.55M 0.02% 948
2017
Q4
$5.38M Buy
805,595
+215,439
+37% +$1.44M 0.01% 1603
2017
Q3
$4.83M Buy
590,156
+342,329
+138% +$2.8M 0.01% 1572
2017
Q2
$1.11M Sell
247,827
-472,226
-66% -$2.12M ﹤0.01% 2180
2017
Q1
$3.97M Buy
720,053
+48,393
+7% +$267K 0.01% 1454
2016
Q4
$2.72M Buy
671,660
+25,170
+4% +$102K 0.01% 1566
2016
Q3
$4.56M Sell
646,490
-28,348
-4% -$200K 0.01% 1284
2016
Q2
$5.5M Sell
674,838
-241,784
-26% -$1.97M 0.01% 1112
2016
Q1
$7.45M Buy
916,622
+572,075
+166% +$4.65M 0.02% 949
2015
Q4
$4.16M Buy
344,547
+156,724
+83% +$1.89M 0.01% 1375
2015
Q3
$2.25M Buy
187,823
+70,006
+59% +$838K ﹤0.01% 1681
2015
Q2
$2.16M Buy
+117,817
New +$2.16M ﹤0.01% 1717